AMP-activated protein kinase regulation of kidney tubular transport

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 5, 2012, Pages 523-533

  Pastor Soler, Núria M ^a   Hallows, Kenneth R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AMP activated protein kinase; channels; metabolism; pumps; transporters

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CHLORIDE CHANNEL; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; METFORMIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CHANNEL; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; URATE;

CELL ENERGY; CELL METABOLISM; CELLULAR STRESS SIGNAL; CHOLESTEROL SYNTHESIS; DIABETES MELLITUS; DRUG SAFETY; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY YIELD; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GAIN OF FUNCTION MUTATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; MEMBRANE TRANSPORT; METABOLIC STRESS; NONHUMAN; NUTRIENT UPTAKE; OSMOTIC STRESS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RENIN RELEASE; REPERFUSION INJURY; REVIEW; URIC ACID BLOOD LEVEL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; ENERGY METABOLISM; HUMANS; ION CHANNELS; KIDNEY TUBULES; SIGNAL TRANSDUCTION;

EID: 84865425780     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283562390     Document Type: Review

References (111)

1. Whittam R. Active cation transport as a pace-maker of respiration. Nature 1961; 191:603-604.
2. Mandel LJ, Balaban RS. Stoichiometry and coupling of active transport to oxidative metabolism in epithelial tissues. Am J Physiol 1981; 240:F357-F371. (Pubitemid 11112946)
3. Hallows KR. Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism. Curr Opin Nephrol Hypertens 2005; 14:464-471. (Pubitemid 41152710)
4. Hallows KR, Mount PF, Pastor-Soler NM, Power DA. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol 2010; 298:F1067-F1077.
5. Gullans SR, Mandel LJ. The Kidney: Physiology and pathophysiology. In: Seldin DW, Giebisch G, editors. Coupling of energy to transport in proximal and distal nephron. Philadelphia, PA: Lippincott, Williams & Wilkins; 2000. pp. 443-482.
6. Mount PF, Hill RE, Fraser SA, et al. Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOSSer1177. Am J Physiol Renal Physiol 2005; 289:F1103-F1115. (Pubitemid 41447067)
7. Hallows KR, Raghuram V, Kemp BE, et al. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 2000; 105:1711-1721. (Pubitemid 30421752)
8. Carattino MD, Edinger RS, Grieser HJ, et al. Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. J Biol Chem 2005; 280:17608-17616. (Pubitemid 41388995)
9. Gong F, Alzamora R, Smolak C, et al. Vacuolar H+-ATPase apical accumulation in kidney intercalated cells is regulated by PKA and AMP-activated protein kinase. Am J Physiol Renal Physiol 2010; 298:F1162-F1169.
10. Li H, Thali RF, Smolak C, et al. Regulation of the creatine transporter by AMPactivated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol 2010; 299:F167-F177.
11. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011; 25:1895-1908.
12. Stapleton D, Mitchelhill KI, Gao G, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271:611-614. (Pubitemid 26034902)
13. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res 2007; 100:474-488. (Pubitemid 46673257)
14. Oakhill JS, Steel R, Chen ZP, et al. AMPK is a direct adenylate chargeregulated protein kinase. Science 2011; 332:1433-1435.
15. Xiao B, Sanders MJ, Underwood E, et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011; 472:230-233.
16. Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2:28.
17. Woods A, Johnstone SR, Dickerson K, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003; 13:2004-2008. (Pubitemid 37425212)
18. Hawley SA, Pan DA, Mustard KJ, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005; 2:9-19. (Pubitemid 43239821)
19. Woods A, Dickerson K, Heath R, et al. Ca2 +calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2:21-33. (Pubitemid 43239822)
20. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 2006; 281:25336-25343. (Pubitemid 44401921)
21. Xie M, Zhang D, Dyck JR, et al. A pivotal role for endogenous TGF-betaactivated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 2006; 103:17378-17383. (Pubitemid 44788977)
22. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998; 67:821-855. (Pubitemid 28411146)
23. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117:5479-5487. (Pubitemid 40012195)
24. Shaw RJ, Bardeesy N, Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6:91-99. (Pubitemid 38903165)
25. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev 2009; 89:1025-1078.
26. Lewy PR, Quintanilla A, Levin NW, Kessler RH. Renal energy metabolism and sodium reabsorption. Annu Rev Med 1973; 24:365-384.
27. Ljungman S. The kidney as a target of hypertension. Curr Hypertens Rep 1999; 1:164-169.
28. Beauge LA, Del Campillo E. The ATP dependence of a ouabain-sensitive sodium efflux activated by external sodium, potassium and lithium in human red cells. Biochim Biophys Acta 1976; 433:547-554.
29. Takiar V, Nishio S, Seo-Mayer P, et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci USA 2011; 108:2462-2467.
30. Deji N, Kume S, Araki S, et al. Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension. Biochem Biophys Res Commun 2012; 418:559-564.
31. Fujii N, Jessen N, Goodyear LJ. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 2006; 291:E867-E877.
32. Fazakerley DJ, Holman GD, Marley A, et al. Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes. J Biol Chem 2010; 285:1653-1660.
33. Hardie DG. Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc Nutr Soc 2011; 70:92-99.
34. Schwenk RW, Dirkx E, Coumans WA, et al. Requirement for distinct vesicleassociated membrane proteins in insulin-and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 2010; 53:2209-2219.
35. Puthanveetil P, Wang F, Kewalramani G, et al. Cardiac glycogen accumulation after dexamethasone is regulated by AMPK. Am J Physiol Heart Circ Physiol 2008; 295:H1753-H1762.
36. Horie T, Ono K, Nagao K, et al. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol 2008; 215:733-742. (Pubitemid 351632695)
37. Nishino Y, Miura T, Miki T, et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 2004; 61:610-619. (Pubitemid 38210166)
38. Russell RR, 3rd, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 1999; 277:H643-H649. (Pubitemid 29415978)
39. Yang J, Holman GD. Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes. J Biol Chem 2005; 280:4070-4078. (Pubitemid 40288570)
40. Barros LF, Baldwin SA, Griffiths M. Rapid activation of GLUT1 by osmotic stress. Biochem Soc Trans 1997; 25:485S. (Pubitemid 27417098)
41. Krimi RB, Letteron P, Chedid P, et al. Resistin-like molecule-beta inhibits SGLT-1 activity and enhances GLUT2-dependent jejunal glucose transport. Diabetes 2009; 58:2032-2038.
42. Sakar Y, Meddah B, Faouzi MA, et al. Metformin-induced regulation of the intestinal D-glucose transporters. J Physiol Pharmacol 2010; 61:301-307.
43. Walker J, Jijon HB, Diaz H, et al. 5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochem J 2005; 385:485-491. (Pubitemid 40173969)
44. Banerjee SK, Wang DW, Alzamora R, et al. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 2010; 49:683-692.
45. Sopjani M, Bhavsar SK, Fraser S, et al. Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Mol Membr Biol 2010; 27:137-144.
46. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl 2011; 120:S1-S6.
47. Welsh MJ, Smith AE. Cystic fibrosis. Sci Am 1995; 273:52-59.
48. King JD Jr, Fitch AC, Lee JK, et al. AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR. Am J Physiol Cell Physiol 2009; 297:C94-C101.
49. Hallows KR, McCane JE, Kemp BE, et al. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J Biol Chem 2003; 278:998-1004. (Pubitemid 36790777)
50. Kongsuphol P, Hieke B, Ousingsawat J, et al. Regulation of Cl-secretion by AMPK in vivo. Pflugers Arch 2009; 457:1071-1078.
51. Boulpaep E. Protein-protein interactions among ion channels regulate ion transport in the kidney. Bull Mem Acad R Med Belg 2009; 164:133-141; discussion 141-132.
52. Stanton BA. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function. Wien Klin Wochenschr 1997; 109:457-464. (Pubitemid 27319407)
53. Lu M, Leng Q, Egan ME, et al. CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney. J Clin Invest 2006; 116:797-807. (Pubitemid 43326889)
54. Li H, Findlay IA, Sheppard DN. The relationship between cell proliferation, Clsecretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int 2004; 66:1926-1938. (Pubitemid 41094317)
55. Bhalla V, Hallows KR. Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol 2008; 19:1845-1854.
56. Woollhead AM, Scott JW, Hardie DG, Baines DL. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells. J Physiol 2005; 566:781-792. (Pubitemid 41122661)
57. Myerburg MM, King JD Jr, Oyster NM, et al. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 2010; 42:676-684.
58. Bhalla V, Oyster NM, Fitch AC, et al. AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2. J Biol Chem 2006; 281:26159-26169. (Pubitemid 44401823)
59. Mace OJ, Woollhead AM, Baines DL. AICAR activates AMPK and alters PIP2 association with the epithelial sodium channel ENaC to inhibit Na+ transport in H441 lung epithelial cells. J Physiol 2008; 586:4541-4557.
60. Almaca J, Kongsuphol P, Hieke B, et al. AMPK controls epithelial Na+ channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Arch 2009; 458:713-721.
61. Liu XS, Jiang M, Zhang M, et al. Electrical remodeling in a canine model of ischemic cardiomyopathy. Am J Physiol Heart Circ Physiol 2007; 292: H560-H571. (Pubitemid 46105219)
62. Demolombe S, Franco D, de Boer P, et al. Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am J Physiol Cell Physiol 2001; 280:C359-C372.
63. Vallon V, Grahammer F, Volkl H, et al. KCNQ1-dependent transport in renal and gastrointestinal epithelia. Proc Natl Acad Sci USA 2005; 102:17864-17869. (Pubitemid 41803588)
64. Zheng W, Verlander JW, Lynch IJ, et al. Cellular distribution of the potassium channel KCNQ1 in normal mouse kidney. Am J Physiol Renal Physiol 2007; 292:F456-F466. (Pubitemid 46105284)
65. Alzamora R, Gong F, Rondanino C, et al. AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. Am J Physiol Renal Physiol 2010; 299:F1308-F1319.
66. Andersen MN, Krzystanek K, Jespersen T, et al. AMP-activated protein kinase downregulates Kv7.1 cell surface expression. Traffic 2012; 13:143-156.
67. Alesutan I, Foller M, Sopjani M, et al. Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase. Mol Membr Biol 2011; 28:79-89.
68. Klein H, Garneau L, Trinh NT, et al. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. Am J Physiol Cell Physiol 2009; 296:C285-C295.
69. Albaqumi M, Srivastava S, Li Z, et al. KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease. Kidney Int 2008; 74:740-749.
70. Ashcroft FM. Adenosine 50-triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988; 11:97-118.
71. Yoshida H, Bao L, Kefaloyianni E, et al. AMP-activated protein kinase connects cellular energy metabolism to KATP channel function. J Mol Cell Cardiol 2011; 52:410-418.
72. Lim A, Park SH, Sohn JW, et al. Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cells. Diabetes 2009; 58:2813-2819.
73. Gimenez I. Molecular mechanisms and regulation of furosemide-sensitive Na-K-Cl cotransporters. Curr Opin Nephrol Hypertens 2006; 15:517-523.
74. Fraser SA, Gimenez I, Cook N, et al. Regulation of the renal-specific Na+-K+-2Cl-co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J 2007; 405:85-93. (Pubitemid 46999928)
75. Gunaratne R, Braucht DW, Rinschen MM, et al. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc Natl Acad Sci USA 2010; 107:15653-15658.
76. Cook N, Fraser SA, Katerelos M, et al. Low salt concentrations activate AMPactivated protein kinase in mouse macula densa cells. Am J Physiol Renal Physiol 2009; 296:F801-F809.
77. Guimbal C, Kilimann MW. A Na+-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. J Biol Chem 1993; 268:8418-8421. (Pubitemid 23118616)
78. Garcia-Delgado M, Peral MJ, Cano M, et al. Creatine transport in brush-border membrane vesicles isolated from rat kidney cortex. J Am Soc Nephrol 2001; 12:1819-1825. (Pubitemid 32801356)
79. Orlowski J, Grinstein S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch 2004; 447:549-565. (Pubitemid 38241440)
80. Marsin AS, Bertrand L, RiderMH, et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000; 10:1247-1255.
81. Boiteux A, Hess B. Design of glycolysis. Philos Trans R Soc Lond B Biol Sci 1981; 293:5-22.
82. Rotte A, Pasham V, Eichenmuller M, et al. Upregulation of Na +H+ exchanger by the AMP-activated protein kinase. Biochem Biophys Res Commun 2010; 398:677-682.
83. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005; 20:125-133. (Pubitemid 40627553)
84. Bataille AM, Maffeo CL, Renfro JL. Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase. Am J Physiol Renal Physiol 2011; 300:F1327-F1338.
85. Hallows KR, Alzamora R, Li H, et al. AMP-activated protein kinase inhibits alkaline pH-and PKA-induced apical vacuolar H+-ATPase accumulation in epididymal clear cells. Am J Physiol Cell Physiol 2009; 296:C672-C681.
86. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 2007; 8:917-929. (Pubitemid 47622561)
87. Wagner CA, Finberg KE, Breton S, et al. Renal vacuolar H+-ATPase. Physiol Rev 2004; 84:1263-1314.
88. Pastor-Soler N, Pietrement C, Breton S. Role of acid/base transporters in the male reproductive tract and potential consequences of their malfunction. Physiology (Bethesda) 2005; 20:417-428. (Pubitemid 41812425)
89. Alzamora R, Thali RF, Gong F, et al. PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the A subunit in kidney cells. J Biol Chem 2010; 285:24676-24685.
90. Al-bataineh MM, Pastor-Soler NM. Vacuolar H+-ATPase regulation by AMPK in the kidney proximal tubule [abstract]. FASEB J 2012; 26:1068.1013.
91. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998; 275:F633-F650.
92. Woollhead AM, Sivagnanasundaram J, Kalsi KK, et al. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells. Br J Pharmacol 2007; 151:1204-1215. (Pubitemid 47255910)
93. Dada LA, Chandel NS, Ridge KM, et al. Hypoxia-induced endocytosis of Na,KATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 2003; 111:1057-1064. (Pubitemid 36397482)
94. Vadasz I, Dada LA, Briva A, et al. AMP-activated protein kinase regulatesCO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. J Clin Invest 2008; 118:752-762. (Pubitemid 351206563)
95. Gusarova GA, Dada LA, Kelly AM, et al. Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol 2009; 29:3455-3464.
96. Gusarova GA, Trejo HE, Dada LA, et al. Hypoxia leads to Na,K-ATPase downregulation via Ca2+ release-activated Ca2+ channels and AMPK activation. Mol Cell Biol 2011; 31:3546-3556.
97. Tan CD, Smolenski RT, Harhun MI, et al. AMP-activated protein kinase (AMPK)-dependent and-independent pathways regulate hypoxic inhibition of transepithelial Na+ transport across human airway epithelial cells. Br J Pharmacol 2012. [Epub ahead of print]
98. Alves DS, Farr GA, Seo-Mayer P, Caplan MJ. AS160 associates with the Na+,K+-ATPase and mediates the adenosine monophosphate-stimulated protein kinase-dependent regulation of sodium pump surface expression. Mol Biol Cell 2010; 21:4400-4408.
99. Seo-Mayer PW, Thulin G, Zhang L, et al. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol Renal Physiol 2011; 301:F1346-F1357.
100. Mount PF, Gleich K, Tam S, et al. The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-beta1 deficient mice. PLoS One 2012; 7: e29887.
101. Fraser S, Mount P, Hill R, et al. Regulation of the energy sensor AMPactivated protein kinase in the kidney by dietary salt intake and osmolality. Am J Physiol Renal Physiol 2005; 288:F578-F586. (Pubitemid 40279465)
102. Morrison A, Li J. PPAR-gamma and AMPK: advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol 2011; 82:195-200.
103. Lempiainen J, Finckenberg P, Levijoki J, Mervaala E. AMPK activator AICAR ameliorates ischemia reperfusion injury in the rat kidney. Br J Pharmacol 2012. [Epub ahead of print]
104. Lin A, Sekhon C, Sekhon B, et al. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation 2004; 78:654-659. (Pubitemid 39244724)
105. Huang DY, Gao H, Boini KM, et al. In vivo stimulation of AMP-activated protein kinase enhanced tubuloglomerular feedback but reduced tubular sodium transport during high dietary NaCl intake. Pflugers Arch 2010; 460:187-196.
106. Boyle JG, Salt IP, McKay GA. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 2010; 27:1097-1106.
107. Viollet B, Guigas B, Sanz Garcia N, et al. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122:253-270.
108. Lee MJ, Feliers D, Mariappan MM, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2007; 292:F617-F627. (Pubitemid 46220529)
109. Guo Z, Zhao Z. Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats. Eur J Pharmacol 2007; 558:208-213. (Pubitemid 46328886)
110. Castaneda-Sceppa C, Castaneda F. Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes. Nutr Rev 2011; 69:720-729.
111. Shah NK, Deeb WE, Choksi R, Epstein BJ. Dapagliflozin: a novel sodiumglucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus. Pharmacotherapy 2012; 32:80-94.